65 related articles for article (PubMed ID: 1112981)
1. Human C3 and C5: subunit structure and modifications by trypsin and C42-C423.
Nilsson UR; Mandle RJ; McConnell-Mapes JA
J Immunol; 1975 Feb; 114(2 pt 2):815-22. PubMed ID: 1112981
[TBL] [Abstract][Full Text] [Related]
2. Cleavage of human C5 by trypsin: characterization of the digestion products by gel electrophoresis.
Minta JO; Man DP
J Immunol; 1977 Nov; 119(5):1597-1602. PubMed ID: 410877
[TBL] [Abstract][Full Text] [Related]
3. Fifth component of guinea pig complement: purification and characterization.
Kinoshita T; Hong K; Kondo K; Inoue K
J Immunol; 1981 Jun; 126(6):2414-8. PubMed ID: 7229382
[TBL] [Abstract][Full Text] [Related]
4. Generation of biologic activity from the purified alpha-chain of C5.
Phan SH; Ward PA
J Immunol; 1979 Dec; 123(6):2735-40. PubMed ID: 501087
[TBL] [Abstract][Full Text] [Related]
5. Proteolysis of the C5b-7 complex: cleavage of the C5b and C6 subunits and its effect on the interaction of the complex with phospholipid bilayers.
Yamamoto KI
J Immunol; 1980 Oct; 125(4):1745-50. PubMed ID: 6997387
[TBL] [Abstract][Full Text] [Related]
6. Activation of the fifth and sixth components of the human complement system: C6-dependent cleavage of C5 in acid and the formation of a bimolecular lytic complex, C5b,6a.
Hammer CH; Hänsch G; Gresham HD; Shin ML
J Immunol; 1983 Aug; 131(2):892-8. PubMed ID: 6863934
[TBL] [Abstract][Full Text] [Related]
7. Structural features and biologic properties of fragments obtained by limited proteolysis of C3.
Conroy MC; Ozols J; Lepow IH
J Immunol; 1976 Jun; 116(6):1682-7. PubMed ID: 774990
[TBL] [Abstract][Full Text] [Related]
8. Generation of C3a anaphylatoxin from human C3 by human mast cell tryptase.
Schwartz LB; Kawahara MS; Hugli TE; Vik D; Fearon DT; Austen KF
J Immunol; 1983 Apr; 130(4):1891-5. PubMed ID: 6339618
[TBL] [Abstract][Full Text] [Related]
9. Expression of C5a-like biological activities by the fifth component of human complement (C5) upon limited digestion with noncomplement enzymes without release of polypeptide fragments.
Wetsel RA; Kolb WP
J Exp Med; 1983 Jun; 157(6):2029-48. PubMed ID: 6222137
[TBL] [Abstract][Full Text] [Related]
10. Evidence for the presence of two pyridine nucleotide-binding sites on the beta subunit of the Escherichia coli pyridine nucleotide transhydrogenase.
Glavas NA; Bragg PD
Biochem Mol Biol Int; 1995 Feb; 35(2):297-306. PubMed ID: 7663384
[TBL] [Abstract][Full Text] [Related]
11. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.
Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
J Immunol; 1983 Nov; 131(5):2570-5. PubMed ID: 6355297
[TBL] [Abstract][Full Text] [Related]
12. The membrane attack complex of complement: relation of C7 to the metastable membrane binding site of the intermediate complex C5b-7.
Preissner KT; Podack ER; Müller-Eberhard HJ
J Immunol; 1985 Jul; 135(1):445-51. PubMed ID: 3998468
[TBL] [Abstract][Full Text] [Related]
13. Active sites in complement components C5 and C3 identified by proximity to indels in the C3/4/5 protein family.
Low PJ; Ai R; Ogata RT
J Immunol; 1999 Jun; 162(11):6580-8. PubMed ID: 10352274
[TBL] [Abstract][Full Text] [Related]
14. Beta-endorphin-related peptides in the human pituitary. Isolation and characterization of major immunoreactive peptides, including the formerly unrecognized peptide beta-endorphin 1-18.
Vuolteenaho O
Acta Physiol Scand Suppl; 1984; 531():1-84. PubMed ID: 6091413
[TBL] [Abstract][Full Text] [Related]
15. The activation of C5 in the fluid phase and in the absence of C3 through the classical pathway of the complement system.
Kitamura H; Tsuboi M; Nagaki K
Immunology; 1986 Jul; 58(3):459-65. PubMed ID: 3733147
[TBL] [Abstract][Full Text] [Related]
16. New subunit in L-phenylalanine oxidase from Pseudomonas sp. P-501 and the primary structure.
Mukouyama EB; Suzuki H; Koyama H
Arch Biochem Biophys; 1994 Feb; 308(2):400-6. PubMed ID: 8109968
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive mass spectrometric analysis of the 20S proteasome complex.
Huang L; Burlingame AL
Methods Enzymol; 2005; 405():187-236. PubMed ID: 16413316
[TBL] [Abstract][Full Text] [Related]
18. Trypsin-activated complex of human factor B with cobra venom factor (CVF), cleaving C3 and C5 and generating a lytic factor for unsensitized guinea pig erythrocytes. II. Physico-chemical characterization of the activated complex.
Miyama A; Kato T; Yokoo J; Kashiba S
Biken J; 1975 Dec; 18(4):205-14. PubMed ID: 1218075
[TBL] [Abstract][Full Text] [Related]
19. The opsonic fragment of the third component of human complement (C3).
Stossel TP; Field RJ; Gitlin JD; Alper CA; Rosen FS
J Exp Med; 1975 Jun; 141(6):1329-47. PubMed ID: 236357
[TBL] [Abstract][Full Text] [Related]
20. Subunit composition and structure of subcomponent C1q of the first component of human complement.
Reid KB; Porter RR
Biochem J; 1976 Apr; 155(1):19-23. PubMed ID: 938474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
